tiprankstipranks
IGM Biosciences Inc (IGMS)
NASDAQ:IGMS

IGM Biosciences (IGMS) Cash flow

270 Followers

IGM Biosciences Cash Flow

IGMS's free cash flow for Q4 2023 was $-49.46M. For the 2023 fiscal year, IGMS's free cash flow was decreased by $-188.55M and operating cash flow was $-48.01M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -192.23M$ -192.23M$ -5.85M$ -124.98M$ -67.30M$ -45.12M
Investing Cash Flow
$ 68.36M$ 68.36M$ -225.64M$ 15.46M$ 57.71M$ -203.24M
Financing Cash Flow
$ 115.07M$ 115.07M$ 219.38M$ 2.48M$ 214.78M$ 282.26M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 580.87M$ 113.11M$ 121.92M$ 134.03M$ 241.08M$ 35.89M
Income Tax Paid Supplemental Data
$ 625.00K$ 625.00K--$ 0.00$ 0.00
Interest Paid Supplemental Data
----$ 0.00$ 297.00K
Issuance Of Capital Stock
$ 1.38M$ 1.38M$ 895.00K$ 905.00K$ 216.19M$ 269.17M
Issuance Of Debt
----$ 0.00$ 15.00M
Repayment Of Debt
------
Free Cash Flow
$ -204.61M$ -204.61M$ -16.06M$ -138.23M$ -84.81M$ -47.45M
Domestic Sales
------
Foreign Sales
------
Currency in USD

IGM Biosciences Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis